Salarius Pharmaceuticals (SLRX) Short Interest Ratio & Short Volume $0.63 +0.03 (+5.12%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$0.64 +0.01 (+1.43%) As of 08/1/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Salarius Pharmaceuticals Short Interest DataSalarius Pharmaceuticals (SLRX) has a short interest of 678,500 shares, representing 32.16% of the float (the number of shares available for trading by the public). This marks a -3.87% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 5.87 million shares to cover all short positions.Current Short Interest678,500 sharesPrevious Short Interest705,800 sharesChange Vs. Previous Month-3.87%Dollar Volume Sold Short$460.70 thousandShort Interest Ratio0.6 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares2,130,000 sharesFloat Size2,110,000 sharesShort Percent of Float32.16%Today's Trading Volume4,042,959 sharesAverage Trading Volume5,871,949 sharesToday's Volume Vs. Average69% Short Selling Salarius Pharmaceuticals? Sign up to receive the latest short interest report for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSLRX Short Interest Over TimeSLRX Days to Cover Over TimeSLRX Percentage of Float Shorted Over Time Salarius Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2025678,500 shares $460.70 thousand -3.9%32.2%0.6 $0.68 6/30/2025705,800 shares $632.33 thousand +2,147.8%33.5%0.6 $0.90 6/15/202531,400 shares $20.64 thousand -34.6%1.5%0 $0.66 5/31/202548,000 shares $37.44 thousand -8.9%2.3%0.2 $0.78 5/15/202552,700 shares $44.78 thousand -37.4%2.5%0.2 $0.85 4/30/202584,200 shares $59.78 thousand -25.4%4.1%0.3 $0.71 4/15/2025112,900 shares $81.29 thousand -18.3%5.4%0.4 $0.72 3/31/2025138,200 shares $104.20 thousand +242.1%8.1%0.1 $0.75 3/15/202540,400 shares $39.19 thousand -52.9%2.4%0 $0.97 2/28/202585,700 shares $92.56 thousand +724.0%5.5%0 $1.08 Get the Latest News and Ratings for SLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/202510,400 shares $16.85 thousand -46.1%0.7%0 $1.62 1/31/202519,300 shares $43.23 thousand -93.8%1.3%0 $2.24 1/15/2025311,700 shares $785.48 thousand +902.3%20.2%0.2 $2.52 12/31/202431,100 shares $57.22 thousand +18.3%2.2%0.1 $1.84 12/15/202426,300 shares $38.66 thousand -27.8%1.9%0.1 $1.47 11/30/202436,400 shares $52.05 thousand -33.8%2.6%0.1 $1.43 11/15/202455,000 shares $73.70 thousand -15.4%3.9%0.2 $1.34 10/31/202465,000 shares $104.65 thousand +4,233.3%4.6%0.2 $1.61 10/15/20241,500 shares $2.28 thousand -90.0%0.1%0 $1.52 9/30/202415,000 shares $21.60 thousand +59.6%1.1%0 $1.44 9/15/20249,400 shares $14.66 thousand -38.6%0.7%0 $1.56 8/31/202415,300 shares $25.40 thousand -64.0%1.1%0 $1.66 8/15/202442,500 shares $85.43 thousand -50.8%3.2%0 $2.01 7/31/202486,300 shares $220.93 thousand +44.1%15.4%0 $2.56 7/15/202459,900 shares $106.62 thousand +215.3%10.7%0 $1.78 6/30/202419,000 shares $45.22 thousand +375.0%27.1%0.9 $2.38 6/15/20244,000 shares $13.53 thousand -85.4%5.7%0.2 $3.38 5/31/202427,300 shares $12.65 thousand -18.5%0.6%0.2 $0.46 5/15/202433,500 shares $15.34 thousand -54.5%0.8%0.3 $0.46 4/30/202473,600 shares $36.73 thousand -36.3%1.7%0.6 $0.50 4/15/2024115,600 shares $57.80 thousand -57.0%2.6%1 $0.50 3/31/2024268,900 shares $142.14 thousand +1,767.4%6.7%2.4 $0.53 3/15/202414,400 shares $9.36 thousand -20.0%0.4%0.1 $0.65 2/29/202418,000 shares $12.06 thousand +227.3%0.5%0.6 $0.67 2/15/20245,500 shares $3.25 thousand -33.7%0.2%0.2 $0.59 1/31/20248,300 shares $4.56 thousand +36.1%0.2%0.2 $0.55 1/15/20246,100 shares $3.72 thousand -37.1%0.2%0.2 $0.61 12/31/20239,700 shares $6.31 thousand +38.6%0.3%0.3 $0.65 12/15/20237,000 shares $4.52 thousand -71.9%0.2%0.1 $0.65 11/30/202324,900 shares $17.68 thousand -56.0%0.7%0.4 $0.71Your blueprint for crypto wealth (Ad)Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Claim your pass to the Crypto Community Summit here (free for a limited time) 11/15/202356,600 shares $40.75 thousand -22.7%1.6%1.1 $0.72 10/31/202373,200 shares $61.33 thousand +136.9%2.3%1.2 $0.84 10/15/202330,900 shares $21.32 thousand +62.6%0.9%0.5 $0.69 9/30/202319,000 shares $12.50 thousand -6.4%0.6%0.3 $0.66 9/15/202320,300 shares $17.40 thousand -26.5%0.6%0.4 $0.86 8/31/202327,600 shares $24.29 thousand +162.9%0.8%0.5 $0.88 8/15/202310,500 shares $7.49 thousand +54.4%0.3%0.2 $0.71 7/31/20236,800 shares $6.25 thousand -60.9%0.2%0.1 $0.92 7/15/202317,400 shares $19.31 thousand -44.8%0.6%0.2 $1.11 6/30/202331,500 shares $46.94 thousand -41.2%1.0%0.3 $1.49 6/15/202353,600 shares $85.22 thousand +9.6%1.7%0.5 $1.59 5/31/202348,900 shares $68.95 thousand -48.4%2.1%0.5 $1.41 5/15/202394,700 shares $136.37 thousand -16.1%4.2%1 $1.44 4/30/2023112,800 shares $200.78 thousand -11.9%5.4%1.3 $1.78 4/15/2023128,000 shares $220.16 thousand +6.1%6.1%2.5 $1.72 3/31/2023120,700 shares $230.54 thousand -4.2%5.8%0.8 $1.91 3/15/2023126,000 shares $255.78 thousand -4.0%6.6%0.7 $2.03 2/28/2023131,300 shares $279.67 thousand +16.7%6.8%0.7 $2.13 2/15/2023112,500 shares $252.00 thousand +11.3%5.9%0.6 $2.24 1/31/2023101,100 shares $260.84 thousand +37.7%5.2%0.6 $2.58 1/15/202373,400 shares $194.51 thousand +272.6%3.8%0.4 $2.65 12/30/202219,700 shares $30.14 thousand -46.6%1.0%0.3 $1.53 12/15/202236,900 shares $55.72 thousand +93.2%1.9%0.8 $1.51 11/30/202219,100 shares $36.86 thousand -12.0%1.0%0.4 $1.93 11/15/202221,700 shares $46.66 thousand +100.9%1.1%0.5 $2.15 10/31/202210,800 shares $21.92 thousand -31.2%0.5%0.3 $2.03 10/15/202215,700 shares $71.04 thousand -95.8%0.8%0.4 $4.53 9/30/2022371,000 shares $72.35 thousand -8.4%N/A0.9 $0.20 9/15/2022405,000 shares $95.90 thousand +9.6%N/A0.8 $0.24 8/31/2022369,500 shares $74.27 thousand -16.3%N/A0.7 $0.20 8/15/2022441,600 shares $99.36 thousand +257.3%N/A0.7 $0.23 7/31/2022123,600 shares $23.51 thousand +7.3%N/A0.1 $0.19 7/15/2022115,200 shares $21.88 thousand -33.8%N/A0.1 $0.19 6/30/2022174,100 shares $36.56 thousand -54.6%N/A0.1 $0.21 6/15/2022383,300 shares $77.73 thousand -9.8%N/A0.3 $0.20 5/31/2022425,000 shares $76.63 thousand -3.8%N/A0.4 $0.18 5/15/2022441,800 shares $83.01 thousand -26.6%N/A0.4 $0.19 4/30/2022602,200 shares $121.64 thousand +31.4%N/A1.1 $0.20 4/15/2022458,300 shares $163.66 thousand -14.7%N/A1.1 $0.36 3/31/2022537,100 shares $213.82 thousand +11.7%N/A1.3 $0.40 3/15/2022480,900 shares $165.43 thousand -23.8%N/A1 $0.34 2/28/2022630,900 shares $252.42 thousand +0.4%N/A1.8 $0.40 2/15/2022628,200 shares $285.83 thousand -3.7%N/A1.7 $0.46 1/31/2022652,400 shares $293.58 thousand -2.0%4.5%1.5 $0.45 1/15/2022665,600 shares $312.83 thousand +4.2%4.6%1.4 $0.47 12/31/2021638,500 shares $316.44 thousand -7.3%4.4%1.3 $0.50 12/15/2021688,600 shares $365.85 thousand -35.0%4.7%1.4 $0.53 11/30/20211,060,000 shares $689 thousand +1.0%7.3%1.5 $0.65 11/15/20211,050,000 shares $796.95 thousand +7.5%7.2%1.1 $0.76 10/29/2021976,600 shares $808.33 thousand -0.2%6.7%0.8 $0.83Your blueprint for crypto wealth (Ad)Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Claim your pass to the Crypto Community Summit here (free for a limited time) 10/15/2021978,900 shares $886.00 thousand -24.1%6.7%0.8 $0.91 9/30/20211,290,000 shares $1.32 million -4.4%8.9%1 $1.02 9/15/20211,350,000 shares $1.39 million -2.9%9.3%1 $1.03 8/31/20211,390,000 shares $1.45 million +9.5%9.6%1 $1.04 8/13/20211,270,000 shares $1.17 million -8.0%8.8%0.7 $0.92 7/30/20211,380,000 shares $1.12 million -9.2%9.5%0.8 $0.81 7/15/20211,520,000 shares $1.38 million -19.2%10.5%0.9 $0.91 6/30/20211,880,000 shares $1.99 million +0.5%13.0%1.1 $1.06 6/15/20211,870,000 shares $2.24 million +14.7%12.9%1.1 $1.20 5/28/20211,630,000 shares $2.09 million -2.4%11.3%1 $1.28 5/14/20211,670,000 shares $2.04 million +29.5%N/A1.3 $1.22 4/30/20211,290,000 shares $1.72 million -5.8%N/A0.6 $1.33 4/15/20211,370,000 shares $1.78 million -12.7%N/A0.6 $1.30 3/31/20211,570,000 shares $2.25 million +41.4%N/A0.6 $1.43 3/15/20211,110,000 shares $1.81 million -41.6%N/A0.4 $1.63 2/26/20211,900,000 shares $3.67 million +15.2%N/A0.7 $1.93 2/12/20211,650,000 shares $4.36 million +202.6%N/A0.6 $2.64 1/29/2021545,200 shares $594.27 thousand -11.3%N/A0.3 $1.09 1/15/2021614,300 shares $712.59 thousand +7.3%N/A0.6 $1.16 12/31/2020572,800 shares $510.94 thousand +22.8%N/A0.7 $0.89 12/15/2020466,600 shares $407.30 thousand -2.1%N/A0.8 $0.87 11/30/2020476,400 shares $325.86 thousand -18.6%N/A1.1 $0.68 11/15/2020585,000 shares $427.05 thousand +3.0%N/A3.9 $0.73 10/30/2020568,000 shares $382.43 thousand -11.4%N/A3.6 $0.67 10/15/2020640,800 shares $583.13 thousand -5.2%N/A2.8 $0.91 9/30/2020675,900 shares $570.39 thousand +22.7%N/A2.9 $0.84 9/15/2020551,100 shares $506.74 thousand -4.2%N/A2.2 $0.92 8/31/2020575,000 shares $540.50 thousand +1.4%N/A1.6 $0.94 8/14/2020567,000 shares $569.84 thousand -40.8%N/A1 $1.01 SLRX Short Interest - Frequently Asked Questions What is Salarius Pharmaceuticals' current short interest? Short interest is the volume of Salarius Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 678,500 shares of SLRX short. 32.16% of Salarius Pharmaceuticals' shares are currently sold short. Learn More on Salarius Pharmaceuticals' current short interest. What is a good short interest ratio for Salarius Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SLRX shares currently have a short interest ratio of 1.0. Learn More on Salarius Pharmaceuticals's short interest ratio. What is a good short interest percentage for Salarius Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 32.16% of Salarius Pharmaceuticals' floating shares are currently sold short. Is Salarius Pharmaceuticals' short interest increasing or decreasing? Salarius Pharmaceuticals saw a drop in short interest in the month of July. As of July 15th, there was short interest totaling 678,500 shares, a drop of 3.9% from the previous total of 705,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Salarius Pharmaceuticals' float size? Salarius Pharmaceuticals currently has issued a total of 2,130,000 shares. Some of Salarius Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Salarius Pharmaceuticals currently has a public float of 2,110,000 shares. How does Salarius Pharmaceuticals' short interest compare to its competitors? 32.16% of Salarius Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Salarius Pharmaceuticals: HCW Biologics Inc. (2.84%), Purple Biotech Ltd. Sponsored ADR (4.67%), Portage Biotech Inc. (9.12%), China Pharma Holdings, Inc. (2.43%), Indaptus Therapeutics, Inc. (3.10%), Sonoma Pharmaceuticals, Inc. (1.78%), Palisade Bio, Inc. (17.10%), Xenetic Biosciences, Inc. (2.62%), AIM ImmunoTech Inc. (414.92%), Briacell Therap (10.57%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Salarius Pharmaceuticals stock? Short selling SLRX is an investing strategy that aims to generate trading profit from Salarius Pharmaceuticals as its price is falling. SLRX shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Salarius Pharmaceuticals? A short squeeze for Salarius Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SLRX, which in turn drives the price of the stock up even further. How often is Salarius Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLRX, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies HCWB Short Interest PPBT Short Interest PRTG Short Interest CPHI Short Interest INDP Short Interest SNOA Short Interest PALI Short Interest XBIO Short Interest AIM Short Interest BCTX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SLRX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Salarius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Salarius Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
